LeonaBio (LONA) Cash from Financing Activities (2019 - 2025)

LeonaBio (LONA) has 7 years of Cash from Financing Activities data on file, last reported at $82.4 million in Q4 2025.

• On a quarterly basis, Cash from Financing Activities rose 242361.76% year-over-year to $82.4 million in Q4 2025; TTM through Dec 2025 was $82.5 million, a 41558.08% increase from a year earlier, with the FY2025 full-year figure at $82.5 million, up 42405.67% from the prior year.
• Cash from Financing Activities for Q4 2025 stood at $82.4 million, up from $34000.0 in the prior quarter.
• Over the last five years, Cash from Financing Activities for LONA reached as high as $97.2 million in Q1 2021 and fell as low as -$260000.0 in Q2 2021.
• Historically, Cash from Financing Activities has averaged $13.9 million across 5 years, with a median of $147000.0 in 2022.
• Across the five-year window, Cash from Financing Activities tumbled 100.3% in 2021 and jumped 242361.76% in 2025, its largest moves.
• Year by year, Cash from Financing Activities stood at $13000.0 in 2021, then soared by 1030.77% to $147000.0 in 2022, then rose by 3.4% to $152000.0 in 2023, then plunged by 77.63% to $34000.0 in 2024, then soared by 242361.76% to $82.4 million in 2025.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were $82.4 million in Q4 2025, $34000.0 in Q4 2024, and $12000.0 in Q3 2024.